<bill session="116" type="h" number="6482" updated="2023-01-11T13:43:15Z">
  <state datetime="2020-04-10">REFERRED</state>
  <status>
    <introduced datetime="2020-04-10"/>
  </status>
  <introduced datetime="2020-04-10"/>
  <titles>
    <title type="display">Protecting Our Pharmaceutical Supply Chain from China Act of 2020</title>
    <title type="official" as="introduced">To require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes.</title>
    <title type="short" as="introduced">Protecting Our Pharmaceutical Supply Chain from China Act of 2020</title>
  </titles>
  <sponsor bioguide_id="G000579"/>
  <cosponsors>
    <cosponsor bioguide_id="B001307" joined="2020-07-01"/>
    <cosponsor bioguide_id="B001302" joined="2020-05-22"/>
    <cosponsor bioguide_id="B001305" joined="2020-04-10"/>
    <cosponsor bioguide_id="C001109" joined="2020-04-10"/>
    <cosponsor bioguide_id="G000582" joined="2020-05-15"/>
    <cosponsor bioguide_id="H001053" joined="2020-05-08"/>
    <cosponsor bioguide_id="L000589" joined="2020-06-08"/>
    <cosponsor bioguide_id="P000599" joined="2020-05-08"/>
    <cosponsor bioguide_id="S001196" joined="2020-04-10"/>
    <cosponsor bioguide_id="T000463" joined="2020-10-27"/>
    <cosponsor bioguide_id="V000133" joined="2020-04-28"/>
  </cosponsors>
  <actions>
    <action datetime="2020-04-10">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-04-10" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2020-04-10">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2020-04-10">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2020-04-10">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2020-04-10">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2020-07-13">
      <text>Referred to the Subcommittee on Oversight and Investigations.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSVR" name="House Veterans' Affairs" subcommittee="" activity="Referral"/>
    <committee code="HSVR08" name="House Veterans' Affairs" subcommittee="Oversight and Investigations" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSAS" name="House Armed Services" subcommittee="" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="3537" relation="identical"/>
    <bill session="116" type="s" number="3635" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Asia"/>
    <term name="Business expenses"/>
    <term name="China"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Income tax deductions"/>
    <term name="Manufacturing"/>
    <term name="Military medicine"/>
    <term name="Military procurement, research, weapons development"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Trade restrictions"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-08T19:42:58Z" status="Introduced in House">Protecting Our Pharmaceutical Supply Chain from China Act of 2020

 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.</summary>
</bill>
